COVID-19: The Ivermectin African Enigma
et al., Colombia Médica, doi:10.25100/cm.v51i4.4613
, COVID-19: The Ivermectin African Enigma, Colombia Médica, doi:10.25100/cm.v51i4.4613
Study of African Programme for Onchocerciasis Control (APOC) countries, which used ivermectin, with non-APOC countries in Africa, showing 28% lower mortality for APOC countries, relative risk RR = 0.72 [0.67-0.78]. See also [colombiamedica.univalle.edu.co] and the author's response [colombiamedica.univalle.edu.co (B)].
Guerrero et al., 22 Oct 2020, peer-reviewed, 5 authors.
Abstract: ORIGINAL ARTICLE
COVID-19: The Ivermectin African Enigma
COVID-19: El enigma africano de la ivermectina
Rodrigo Guerrero1 , Luis Eduardo Bravo2,3
Ardila5 , Esteban Guerrero6
,Edgar Muñoz4
,Elvia Karina Grillo
luis.bravo@correounivalle.com
1 Universidad del Valle, Instituto de Investigación y Desarrollo en Prevención de la Violencia
y Promoción de la Convivencia Social, CISALVA, Cali, Colombia., 2 Universidad del Valle,
Facultad de Salud, Escuela de Medicina, Departamento de Patología, Cali, Colombia, 3 Registro
Poblacional de Cáncer, Cali, Colombia. 4 University of Texas , Health Science Center San
Antonio, Texas, USA. 5 Universidad del Valle, Facultad de Salud, Doctorado en Salud, Cali,
Colombia. 6 Barbara & Frick. Bogotá. Colombia.
Abstract
Loading..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.